Cargando…

Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines

BACKGROUND: Grading of Recommendations Assessment, Development, and Evaluation (GRADE) is a systematic approach to grading strength of recommendation (SOR) and quality of evidence (QOE) for guideline recommendations. We aimed to assess the relationship between SOR and QOE in current Infectious Disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Miles, Kaitlin E, Rodriguez, Ryan, Gross, Alan E, Kalil, Andre C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885855/
https://www.ncbi.nlm.nih.gov/pubmed/33614818
http://dx.doi.org/10.1093/ofid/ofab033
_version_ 1783651682788311040
author Miles, Kaitlin E
Rodriguez, Ryan
Gross, Alan E
Kalil, Andre C
author_facet Miles, Kaitlin E
Rodriguez, Ryan
Gross, Alan E
Kalil, Andre C
author_sort Miles, Kaitlin E
collection PubMed
description BACKGROUND: Grading of Recommendations Assessment, Development, and Evaluation (GRADE) is a systematic approach to grading strength of recommendation (SOR) and quality of evidence (QOE) for guideline recommendations. We aimed to assess the relationship between SOR and QOE in current Infectious Diseases Society of America (IDSA) guidelines. METHODS: In this cross-sectional analysis, we analyzed the frequency of SOR-QOE pairings, including discordance (defined as strong SOR based on expert opinion, very low, or low QOE) for GRADEd recommendations in IDSA guidelines published since 2010. Data for each recommendation were extracted on SOR, QOE, the domain of disease management (one or more of diagnosis, treatment, prevention, and other categories), and relevance to drug or nondrug treatment. RESULTS: Seventeen eligible guidelines provided 1042 unique GRADEd recommendations (n = 237, 711, 76, and 73 pertaining to diagnosis, treatment, prevention, and other domains, respectively; n = 574 and 137 pertaining to drug and nondrug treatment). Overall, the most common SOR was strong (71.8%; n = 748) and the most common QOE was low (48.6%; n = 506). Among all strong recommendations, 47.1% (n = 352) demonstrated discordance with QOE. By domain, strong recommendations were discordant in 36.6%, 51.4%, 29.3%, and 58.1% of recommendations pertaining to diagnosis, treatment, prevention, and other domains, respectively. Similarly, 50.7% and 54.0% of strong recommendations related to drug and nondrug treatment were discordant, respectively. We identified 39.6% of discordant recommendations to be consistent with good practice statements, which are recommended to be labeled as such without formal GRADEd designations of SOR or QOE. CONCLUSIONS: Among all IDSA guideline recommendations with strong SOR, approximately half were discordant with QOE, and this frequency varied across strata of domains of disease management.
format Online
Article
Text
id pubmed-7885855
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-78858552021-02-19 Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines Miles, Kaitlin E Rodriguez, Ryan Gross, Alan E Kalil, Andre C Open Forum Infect Dis Major Articles BACKGROUND: Grading of Recommendations Assessment, Development, and Evaluation (GRADE) is a systematic approach to grading strength of recommendation (SOR) and quality of evidence (QOE) for guideline recommendations. We aimed to assess the relationship between SOR and QOE in current Infectious Diseases Society of America (IDSA) guidelines. METHODS: In this cross-sectional analysis, we analyzed the frequency of SOR-QOE pairings, including discordance (defined as strong SOR based on expert opinion, very low, or low QOE) for GRADEd recommendations in IDSA guidelines published since 2010. Data for each recommendation were extracted on SOR, QOE, the domain of disease management (one or more of diagnosis, treatment, prevention, and other categories), and relevance to drug or nondrug treatment. RESULTS: Seventeen eligible guidelines provided 1042 unique GRADEd recommendations (n = 237, 711, 76, and 73 pertaining to diagnosis, treatment, prevention, and other domains, respectively; n = 574 and 137 pertaining to drug and nondrug treatment). Overall, the most common SOR was strong (71.8%; n = 748) and the most common QOE was low (48.6%; n = 506). Among all strong recommendations, 47.1% (n = 352) demonstrated discordance with QOE. By domain, strong recommendations were discordant in 36.6%, 51.4%, 29.3%, and 58.1% of recommendations pertaining to diagnosis, treatment, prevention, and other domains, respectively. Similarly, 50.7% and 54.0% of strong recommendations related to drug and nondrug treatment were discordant, respectively. We identified 39.6% of discordant recommendations to be consistent with good practice statements, which are recommended to be labeled as such without formal GRADEd designations of SOR or QOE. CONCLUSIONS: Among all IDSA guideline recommendations with strong SOR, approximately half were discordant with QOE, and this frequency varied across strata of domains of disease management. Oxford University Press 2021-01-21 /pmc/articles/PMC7885855/ /pubmed/33614818 http://dx.doi.org/10.1093/ofid/ofab033 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles
Miles, Kaitlin E
Rodriguez, Ryan
Gross, Alan E
Kalil, Andre C
Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines
title Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines
title_full Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines
title_fullStr Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines
title_full_unstemmed Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines
title_short Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines
title_sort strength of recommendation and quality of evidence for recommendations in current infectious diseases society of america guidelines
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885855/
https://www.ncbi.nlm.nih.gov/pubmed/33614818
http://dx.doi.org/10.1093/ofid/ofab033
work_keys_str_mv AT mileskaitline strengthofrecommendationandqualityofevidenceforrecommendationsincurrentinfectiousdiseasessocietyofamericaguidelines
AT rodriguezryan strengthofrecommendationandqualityofevidenceforrecommendationsincurrentinfectiousdiseasessocietyofamericaguidelines
AT grossalane strengthofrecommendationandqualityofevidenceforrecommendationsincurrentinfectiousdiseasessocietyofamericaguidelines
AT kalilandrec strengthofrecommendationandqualityofevidenceforrecommendationsincurrentinfectiousdiseasessocietyofamericaguidelines